Guidelines

This page provides a selection of up-to-date clinical guidelines and expert recommendations in the fields of addiction medicine and general psychiatry. The collection includes documents in English, German, French, and Italian, offering evidence-based guidance for professionals across medical, psychiatric, and psychosocial care settings.

Topics covered range from the management of substance use disorders (such as alcohol, opioids, cannabis, and stimulants) to behavioral addictions, psychiatric comorbidities, and general mental health practices.

All guidelines are regularly updated

All listed guidelines are available for direct download in PDF format.

SAMHSA

Medications for Opioid Use Disorder

2021

Guidelines

Medications for Opioid Use Disorder

National Practice Guideline for the Treatment of Opioid Use Disorder

Leitlinie – Qualitätsstandards für die Opioid-Substitutions-Therapie

Management of opioid use disorder: 2024 update to the national clinical practice guideline

Évaluation et prise en charge des syndromes psychotraumatiques

APA GUIDELINES for Working with Adults with Complex Trauma Histories

Quality Prescribing for Benzodiazepines and z-drugs

Benzodiazepine and Z-Drug Safety Guideline

Australian Evidence-Based Clinical Guideline For Attention Deficit Hyperactivity Disorder (ADHD)

Attention deficit hyperactivity disorder: diagnosis and management

Treatment of alcohol use disorder: position paper of the Società Italiana di Alcologia (SIA)

Sex, Gender and Alcohol - What Matters for Women in Low-Risk Drinking Guidelines?

Posttraumatische Belastungsstörung: S3 Leitlinie der Deutschsprachigen Gesellschaft für Psychotraumatologie

S3-Leitlinie Schizophrenie

S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen

S3-Leitlinie“ Rauchen und Tabakabhängigkeit: Screening,Diagnostik und Behandlung”

International Standards on Drug Use Prevention

S3-Leitlinie Essstörungen

S3-Leitlinie „Verhinderung von Zwang: Prävention undTherapie aggressiven Verhaltens bei Erwachsenen“

National PracticeGuideline for the Treatment of Opioid Use Disorder

International Standards on Drug Use Prevention

Social anxiety disorder:recognition, assessmentand treatment

Normesinternationalespour le traitementdes troubles liés àla consommationde drogues

Gambling-related harms:identification, assessmentand management

La capacité de discernement dans la pratique médicale

Medical use ofcannabis andcannabinoids

Opioid Substitution Treatment in Custodial Settings

National Guidelines for Medication-Assisted Treatment of Opioid Dependence

Clinical Guidelines for Opioid Substitution Treatment

VA/DoD CLINICAL PRACTICE GUIDELINE FOR MANAGEMENT OF POSTTRAUMATIC STRESS DISORDER AND ACUTE STRESS DISORDER

APA CLINICAL PRACTICE GUIDELINE for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults

PRACTICE GUIDELINE FOR THE Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder

Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults

Deprescribing benzodiazepine receptor agonists

Attention deficit hyperactivity disorder (ADHD) in adults: Good practice guidelines

International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder

Linee di Indirizzo Intersocietarie su Diagnosi e Cura del Disturbo da Uso di Alcol (DUA)

Substance Use Harm Reduction in Medical Care

S3-Leitlinie Psychosoziale Therapien bei schweren psychischen Erkrankungen

S3-Leitlinie Methamphetamin-bezogene Störungen

Richtlinie der Bundesärztekammer zur Durchführung der substitutionsgestützten Behandlung Opioidabhängiger

Self-harm: assessment,management andpreventing recurrence

Bipolar disorder:assessment andmanagement

Preventing suicide incommunity and custodialsettings

Antisocial behaviour andconduct disorders inchildren and young people:recognition andmanagement

Violence and aggression:short-term management inmental health, health andcommunity settings

Drug misuse and dependence

Borderline-Persönlichkeitsstörung

The ASAM/AAAP Clinical Practice Guideline on the Managementof Stimulant Use Disorder

Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder

Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence

Traitements agonistes opioïdesPrincipes directeurs pourles législations et réglementations

Medizinische Empfehlungen für Opioidagonistentherapie (OAT) bei Opioidabhängigkeits-Syndrom

Medication Assisted Treatment (MAT) Standards for Scotland

A Guideline for the Clinical Management of Opioid Use Disorder

GUIDE DE PRATIQUE POUR L’EVALUATION ET LE TRAITEMENT COGNITIVO-COMPORTEMENTAL DU TROUBLE DU STRESS POST- TRAUMATIQUE

Post-traumatic stress disorder

TROUBLE STRESS POST-TRAUMATIQUE

Benzodiazepine Tapering: Considerations when Benzodiazepine Risks Outweigh Benefits

Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances

Canadian ADHD Practice Guidelines

Assertive Community Treatment (ACT) Program Guidelines Adult and Young Adult

Guidelines on drug prevention and treatment for girls and women

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence

S3-Leitlinie zur Diagnostik und Therapie Bipolarer Störungen

Management of alcohol-related liver disease

Therapie der Opiatabhängigkeit – Teil 1: Substitutionsbehandlung

Autismus-Spektrum-Störungen imKindes-, Jugend- und ErwachsenenalterTeil 1: Diagnostik

LIVE LIFEAn implementation guide for suicide prevention in countries

Community managementof opioid overdose

Behandlung von Angststörungen

S3-LeitlinieDemenzen

Treatment of StimulantUse Disorders

Trattamento del disturbo da uso di alcol

Internationale Standards zurPrävention des Drogenkonsums

Ligne directrice canadienne pour la prise en charge clinique de la consommation d’alcool à risque élevé et du trouble d’utilisation de l’alcool

International standards for the treatment of drug use disorders

S3-Leitlinie
“ Rauchen und Tabakabhängigkeit: Screening,
Diagnostik und Behandlung”

S3-Leitlinie „Verhinderung von Zwang: Prävention und
Therapie aggressiven Verhaltens bei Erwachsenen“

National Practice

Guideline for the Treatment of Opioid Use Disorder

Social anxiety disorder:
recognition, assessment
and treatment

Normes
internationales
pour le traitement
des troubles liés à
la consommation
de drogues

Gambling-related harms:
identification, assessment
and management

Medical use of
cannabis and
cannabinoids

Self-harm: assessment,
management and
preventing recurrence

Bipolar disorder:
assessment and
management

Preventing suicide in
community and custodial
settings

Antisocial behaviour and
conduct disorders in
children and young people:
recognition and
management

Violence and aggression:
short-term management in
mental health, health and
community settings

The ASAM/AAAP Clinical Practice Guideline on the Management
of Stimulant Use Disorder

Traitements agonistes opioïdes
Principes directeurs pour
les législations et réglementations

Autismus-Spektrum-Störungen im
Kindes-, Jugend- und Erwachsenenalter
Teil 1: Diagnostik

LIVE LIFE
An implementation guide for suicide prevention in countries

Community management
of opioid overdose

S3-Leitlinie
Demenzen

Treatment of Stimulant
Use Disorders

Internationale Standards zur
Prävention des Drogenkonsums